Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Oaktree Acquisition Corp. III Life Sciences (OACC)

Oaktree Acquisition Corp. III Life Sciences CFO Thomas Sweeney resigns; George Martinez named CFO

Neutral Impact 3 of 5 leadership Written later

Chief Financial Officer Thomas Sweeney resigned effective October 29, 2025, to pursue other professional opportunities, according to the filing, and the filing states the resignation was not due to any disagreement with the board or management. The board appointed George A. Martinez, a Senior Vice President in Oaktree's finance organization, as CFO effective immediately, and he will not receive compensation from the company for the role.

Key points

  • Thomas Sweeney resigned as Chief Financial Officer effective October 29, 2025, citing other professional opportunities
  • George A. Martinez appointed Chief Financial Officer and principal accounting and financial officer effective October 29, 2025
  • Martinez previously was an Audit Senior Manager at Ernst & Young from 2013 to 2024 and joined Oaktree in 2024
  • Martinez will not be compensated by the company for the CFO role and has no employment agreement with it

The filing

CompanyOaktree Acquisition Corp. III Life Sciences (OACC)
Form8-K, current report
Filed with the SECOct 29, 2025, 5:00 PM ET
Accession number0001193125-25-256604

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 29, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.